Home / Health / UK Report Ignored in Aussie Blocker Decision
UK Report Ignored in Aussie Blocker Decision
16 Nov
Summary
- Australia endorsed puberty blockers, dismissing the UK's Cass review.
- Federal guidance relies on evidence of 'low certainty'.
- The NHMRC is responsible for the decision in Australia.
Australia has decided to permit puberty blockers for adolescents, a move that sidelines the conclusions of the United Kingdom's comprehensive Cass review. The National Health and Medical Research Council (NHMRC) in Canberra issued federal guidance that endorses this treatment.
Reports indicate that the NHMRC's decisionmaking process relied on evidence assessed as having 'low certainty.' This stance contrasts sharply with the cautious approach taken in the UK following the extensive review, suggesting a different interpretation of the available research on gender-affirming treatments for young people.